Unitas Global Acquires INAP's Network Business Assets
Unitas Global, a Digital Alpha portfolio company, announces today that it has acquired INAP’s Network Business assets, including INAP Japan, enhancing its portfolio of network service offerings that enable hybrid cloud environments. The combination of these two companies creates a high-growth next generation networking platform focused on simplifying the way customers buy network connectivity to enable the seamless movement of data between various cloud and on-premises environments.
The combination of the INAP network technologies, including its patented, intelligent routing software, Managed Internet Route Optimizer (MIRO), with Unitas Global's automated design and pricing platform, Unitas Nexus™, and its global network, Unitas Reach™, creates a compelling offer to meet the needs of enterprises modernizing their digital infrastructure. In addition, this acquisition provides Unitas Global with a significant expansion of over a thousand multinational enterprise customers as well as global network serving 18 markets with Performance IP™.
"We are thrilled to have completed the acquisition of INAP's Network Business and excited to welcome their customers, vendors and employees to the Unitas Global team," comments Patrick Shutt, CEO of Unitas Global. "The disruptive nature of Unitas' networking services strategy that enables hybrid cloud environments has become increasingly self-evident in the market. This acquisition is the next step to become the market leader redefining an agile hybrid cloud for the enterprise," comments Grant Kirkwood, CTO of Unitas Global.
An additional benefit of the transaction is the synergy of INAP becoming a strategic customer of Unitas Global. INAP will continue to offer high-performance connectivity services alongside its colocation and cloud solutions, further expanding its portfolio with Unitas Reach™ network transformation solutions, including the most recent alliance announcement with PacketFabric.
“The transaction is a true win-win for everyone involved. Unitas Global will continue to provide the high-quality services that customers enjoy today while investing in new solutions to enable further network transformation tomorrow," comments Mike Sicoli, CEO of INAP. "We also look forward to partnering with Unitas Global to bring an expanded portfolio of connectivity offerings to our colocation and cloud customers."
"The acquisition of INAP’s Network Business assets is a powerful proof point of Digital Alpha's commitment to investing in and developing transformative next generation networks that provide a more holistic networking-as-a-service solution in the currently fragmented marketplace," states Rick Shrotri Managing Partner of Digital Alpha Advisors.
For more information, visit: https://www.unitasglobal.com/
About Unitas Global
Unitas Global is a next-generation network service provider offering automated ubiquitous edge access to cloud everywhere. The combination of its Unitas Nexus™ platform and global Unitas Reach™ network provides the most transformative network environments that are easy to design, procure, and fully managed. Analyzing price and performance requirements in real-time makes Unitas Nexus™ one of the most advanced go-to-market platforms for MSPs, hyperscale cloud providers, and datacenter operators worldwide. Unitas Reach™ access, IP, and SDN provide cost-optimized network connectivity with the agility needed to scale quickly and support the growing demands of applications on network architectures, performance, and costs. Unitas Global is a Digital Alpha Advisors portfolio company. Learn more at unitasglobal.com or connect with Unitas at LinkedIn, Twitter, and its Blog.
INAP is a global provider of performance-driven, secure hybrid infrastructure solutions, enabling technology leaders to simplify their cloud journeys and accelerate innovation. INAP's expansive suite of bare metal cloud, modern data center, optimized network and security solutions help businesses flexibly and reliably move workloads to the right destination at the right time to maximize the results of their IT strategy. For more information, visit www.inap.com
About Digital Alpha Advisors, LLC
Digital Alpha Advisors, LLC is an investment firm focused on digital infrastructure required by the rapidly expanding digital economy, with total assets under management of over $1.5B. The firm has a strategic collaboration agreement with Cisco Systems, Inc. and has partnered with other leading Silicon Valley firms. Digital Alpha believes it is the first firm focused on making private equity investments in the significant growth opportunities required to underpin the Digital Economy, including next generation communications networks, IoT platforms for urban infrastructure, and cloud-based data management platforms. Digital Alpha was founded in 2017 by Rick Shrotri, former Head of the Global Infrastructure Funds (GIF) team at Cisco, and closed its latest Fund – Digital Alpha Fund II, LP – in early 2021. For more information, please visit www.digitalalpha.net.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Media Contacts for Unitas Global:
iMiller Public Relations
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Data from Incyte’s Robust and Progressing Oncology Portfolio to be Presented at 2022 EHA Annual Meeting26.5.2022 12:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its oncology portfolio will be presented at the upcoming European Hematology Association 2022 (EHA2022) Congress (June 9-17; virtual and in Vienna). “We are committed to advancing science that can lead to solutions for patients with serious unmet medical needs, including those with cancer,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “For that reason, we look forward to convening with the oncology community and presenting data from across our portfolio, including both Incyte-led and partnered programs.” Key abstracts accepted by EHA include: Oral Presentation Long-term Efficacy and Safety Results from an Ongoing Open-Label Phase 2 Study of Parsaclisib for the Treatment of Autoimmune Hemolytic Anemia (AIHA) (Abstract #S286. Session: Transfusion and Autoimmune Hemolytic Anemia. Session Time: Friday, June 10, 11:30 a.m. - 12:45 p.m.) Poster Presentations A Real-World Evaluation of the Association
H.I.G. Capital Expands Its Capital Formation Middle East Team with the Addition of Oliver Slade26.5.2022 12:00:00 CEST | Press release
H.I.G. Capital, LLC ("H.I.G."), a leading global alternative investment firm with over $49 billion of capital under management, is pleased to announce that Oliver Slade has joined the firm’s Capital Formation Group, as a Managing Director, based in Dubai. Oliver will be responsible for capital raising and investor relations activities in the Middle East. He has been based in the region since 2008 and has over 17 years of experience in alternative assets. Oliver joins H.I.G. from Partners Group, where he was the Head of Middle East and Africa, responsible for the development and capital raising activities across private markets funds and solutions in the region. Prior to Partners Group, Oliver held a similar role at GAM investments. Jordan Peer Griffin, Executive Managing Director and Global Head of Capital Formation, commented: “We are delighted to welcome Oliver to H.I.G. Given his experiences in the region, Oliver is a key addition to establish a local presence in the Middle East, wh
500 Billion Gallons of Water Prevented from Flooding Communities in 2021, Using Xylem Technology26.5.2022 12:00:00 CEST | Press release
Solutions from global water technology company Xylem (NYSE:XYL), helped prevent more than 500 billion gallons of polluted water from flooding communities in 2021, according to its annual Sustainability Report. The report highlights the Company’s work with customers and partners to solve the world’s greatest water challenges. It also details Xylem’s progress to reduce its operational footprint, including cutting Scope 1 and 2 greenhouse gas (GHG) emission intensity by 12 percent and water use by 22 percent, versus 2019. “It’s a great privilege to have a leading portfolio of technologies and services to help our customers and communities solve the water challenges so central to a more sustainable world,” said Patrick Decker, president and CEO of Xylem. “We have a responsibility to make a difference, working alongside our customers and partners, and the communities we all serve. That’s why our sustainability report is more than a set of numbers. It’s a report card on the difference we’re
SCREEN Increases Efforts to Reduce the Environmental Impact of the Semiconductor Industry26.5.2022 10:43:00 CEST | Press release
SCREEN Semiconductor Solutions Co., Ltd. (SCREEN SPE), a subsidiary of SCREEN Holdings Co., Ltd., has announced it will increase its efforts to reduce the company’s environmental overall impact. The SCREEN Group is committed to both achieving a sustainable global society and to improving its sustainable value (social value) and has formulated a medium-term management plan titled Sustainable Value 2023 targeting these goals. The plan identifies specific issues in each of the environmental, social, and governance (ESG) fields. Concerning the environment, SCREEN is working to provide products and services that actively contribute to the reduction of ecological burden. Its efforts include improving the environmental performance of its products, reducing the effects of its business activities on climate change, promoting effective utilization of water resources, increasing recycling of products and parts, and helping to preserve biodiversity. Concretely, SCREEN SPE seeks to reduce the impac
CARVYKTI ® (ciltacabtagene autoleucel) Granted Conditional Approval by the European Commission for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma26.5.2022 09:10:00 CEST | Press release
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced that the European Commission (EC) has granted conditional marketing authorization of CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed and refractory multiple myeloma (RRMM) who have received at least three prior therapies, including a proteasome inhibitor (PI), an immunomodulatory agent (IMiD) and an anti-CD38 antibody, and have demonstrated disease progression on the last therapy. Legend Biotech entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc. (Janssen) to develop and commercialize cilta-cel in December 2017. CARVYKTI® is a chimeric antigen receptor T-cell (CAR-T) therapy featuring two B-cell maturation antigen (BCMA)-targeting single domain antibodies.1 CAR-T therapy is specifically developed
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom